Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with3,5-dibromo-N,a-dimethylbenzenemethanamine (1:1) (644982-28-5)

Identification
Name:	Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with3,5-dibromo-N,a-dimethylbenzenemethanamine (1:1)
CAS:	644982-28-5
Molecular Structure:
Properties
Safety Data

Other Product

Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with3,5-dichloro-N,a-dimethylbenzenemethanamine (1:1)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with3,5-dichloro-N,a-dimethylbenzenemethanamine (1:1)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with(2S,4E)-N-methyl-5-[5-(1-methylethoxy)-3-pyridinyl]-4-penten-2-amine(1:2)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with(3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine (1:2)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. withrel-(3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine (1:2)
Butanedioic acid, 2,3-bis[(4-Methylbenzoyl)oxy]-, (2R,3R)-, coMpd. with (1R,2R)-2-[(phenylMethyl)aMino]cyclohexanol (1:2)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with(3E)-N-methyl-4-(3-pyridinyl)-3-buten-1-amine (1:1)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with(1S)-1-amino-1,3,4,5-tetrahydro-3-methyl-2H-3-benzazepin-2-one (1:1)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with(3R)-phenylmethyl 3-amino-2-oxo-1-pyrrolidinecarboxylate (1:2)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. withethyl (3R)-3-methyl-3-piperidinecarboxylate (1:2)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with(2S,4E)-N-methyl-5-[5-(1-methylethoxy)-3-pyridinyl]-4-penten-2-amine(1:2)
Butanedioic acid,2,3-bis[(4-methylbenzoyl)oxy]-, hydrate (1:1), (2R,3R)-
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-rel-
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with(3S)-phenylmethyl 3-amino-2-oxo-1-pyrrolidinecarboxylate (1:2)
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. withrel-(2R,5S)-2,5-dimethyl-1-(2-propenyl)piperazine (1:1)
(2R,3R)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid - 6,8-dimethyl-1-pentyl-8,9-didehydroergoline (1:1)
4-[(1S)-(4-Dimethylamino)-1-(4-fluotophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (2R,3R)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid
Formic acid, compd. with3-[3-[[7-[[(2R)-2-(3-fluoro-4-hydroxyphenyl)-2-hydroxyethyl]amino]heptyl]oxy]propyl]benzenesulfonamide (1:1)
(R)-3-(2-(benzyloxy)-5-bromophenyl)-N,N-diisopropyl-3-phenylpropan-1-amine (2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinate
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with4-[(1R)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:1)